Medifast
MED
224 hedge funds and large institutions have $1.69B invested in Medifast in 2020 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 66 increasing their positions, 77 reducing their positions, and 27 closing their positions.
167% more funds holding in top 10
Funds holding in top 10: 3 → 8 (+5)
116% more capital invested
Capital invested by funds: $781M → $1.69B (+$906M)
85% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 27
11% more funds holding
Funds holding: 202 → 224 (+22)
3.11% less ownership
Funds ownership: 106.29% → 103.17% (-3.1%)
14% less repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 77
90% less call options, than puts
Call options by funds: $18.3M | Put options by funds: $182M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LOAMU
Lombard Odier Asset Management (USA)
New York
|
+$7.2M |
| 2 |
Morgan Stanley
New York
|
+$6.86M |
| 3 |
BlackRock
New York
|
+$6.28M |
| 4 |
CM
Castleark Management
Chicago,
Illinois
|
+$5.21M |
| 5 |
Nordea Investment Management
Stockholm,
Sweden
|
+$4.67M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MVP
Miller Value Partners
Sarasota,
Florida
|
-$14M |
| 2 |
1M
13D Management
New York
|
-$9.43M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$8.93M |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
-$8.26M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$6.09M |
MED Hedge Fund Activity: Q2 2020 in Review
224 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q2 2020, worth a combined $1.69B — up 116% from $781M a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new MED positions and 27 closed out — a net gain of 23 holders — while 66 added to existing stakes and 77 trimmed.
The largest buyer was Lombard Odier Asset Management (USA), adding an estimated $7.2M. The largest seller was Miller Value Partners, cutting an estimated $14M.
- 224 institutional investors held Medifast (MED) as of Q2 2020, up from 202 in Q1 2020.
- Funds reported $1.69B of Medifast stock for Q2 2020, up 116% quarter-over-quarter.
- 50 funds opened new Medifast positions in Q2 2020 and 27 closed out, a net change of +23 holders.
- The largest Medifast buyer in Q2 2020 was Lombard Odier Asset Management (USA), an estimated $7.2M added.
- The largest Medifast seller in Q2 2020 was Miller Value Partners, an estimated $14M sold.
Based on aggregated 13F filings for Q2 2020.